Gaucher Disease

• FDA approval · 2016-06-08
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  FDA approved a supplemental application for Cerezyme (imiglucerase) submitted by Genzyme Corporation.

• FDA approval · 2016-04-21
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  FDA approved a supplemental application for Cerezyme (imiglucerase) by Genzyme Corporation.

• FDA approval · 2016-03-03
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  The FDA approved a supplemental application for Cerezyme (imiglucerase) from Genzyme Corporation.

• FDA approval · 2016-02-25
  FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  The FDA approved a supplemental application for ELELYSO (taliglucerase alfa) from Pfizer Laboratories Div Pfizer Inc. The approval involves …

• FDA approval · 2016-01-11
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for VPRIV (velaglucerase alfa) submitted by Takeda Pharmaceuticals America, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2015-12-23
  FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approved a supplemental application for ELELYSO (taliglucerase alfa) submitted by Pfizer Laboratories Div Pfizer Inc.

• FDA approval · 2015-11-20
  FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  The FDA approved a supplemental application for Elelyso (taliglucerase alfa) submitted by Pfizer Laboratories Div Pfizer Inc.

• FDA approval · 2015-08-10
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  FDA approved a supplemental application for CEREZYME (imiglucerase) from Genzyme Corporation.

• FDA approval · 2015-05-11
  FDA Approved: CERDELGA — Supplemental Application (Genzyme Corporation)

  The FDA approved a supplemental application for CERDELGA (Eliglustat) filed by Genzyme Corporation.

• FDA approval · 2015-05-05
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for VPRIV (velaglucerase alfa) from Takeda Pharmaceuticals America, Inc., updating the drug's la…

• FDA approval · 2015-03-09
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  FDA approved a supplemental application for Cerezyme (imiglucerase) from Genzyme Corporation.

• FDA approval · 2014-12-02
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for VPRIV (velaglucerase alfa) from Takeda Pharmaceuticals America, Inc. The approval pertains to a …

• FDA approval · 2014-09-05
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  The FDA approved a supplemental application for Cerezyme (imiglucerase) submitted by Genzyme Corporation.

• FDA approval · 2014-08-27
  FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  The FDA approved a supplemental application for ELELYSO (taliglucerase alfa) from Pfizer Laboratories Div Pfizer Inc.

• FDA approval · 2014-07-11
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA has approved a supplemental application for VPRIV (velaglucerase alfa) from Takeda Pharmaceuticals America, Inc.

• FDA approval · 2014-06-24
  FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  The FDA approved a supplemental application for ELELYSO (taliglucerase alfa) submitted by Pfizer Laboratories Div Pfizer Inc.

• FDA approval · 2014-06-18
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for VPRIV (velaglucerase alfa) submitted by Takeda Pharmaceuticals America, Inc.

• FDA approval · 2014-02-27
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  FDA approved a supplemental application for Cerezyme (imiglucerase) from Genzyme Corporation. This action concerns the approval of an additi…

• FDA approval · 2014-02-11
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for VPRIV (velaglucerase alfa) submitted by Takeda Pharmaceuticals America, Inc. The document indica…

• FDA approval · 2014-01-13
  FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  The FDA has approved a supplemental application for Elelyso (taliglucerase alfa) from Pfizer Laboratories Div Pfizer Inc.

• FDA approval · 2013-11-21
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for VPRIV (velaglucerase alfa) submitted by Takeda Pharmaceuticals America, Inc. This action rel…

• FDA approval · 2013-10-30
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  The FDA approved a supplemental application for Cerezyme (imiglucerase) from Genzyme Corporation.

• FDA approval · 2013-10-02
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for VPRIV (velaglucerase alfa) submitted by Takeda Pharmaceuticals America, Inc., approving chan…

• FDA approval · 2013-07-31
  FDA Approved: CEREZYME — Supplemental Application (Genzyme Corporation)

  The FDA approved a supplemental application for Cerezyme (imiglucerase) submitted by Genzyme Corporation. This action finalizes changes to t…

• FDA approval · 2013-06-03
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for VPRIV (velaglucerase alfa) from Takeda Pharmaceuticals America, Inc.